GAM
BIO icon

Gotham Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Gotham Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.5M Buy
152,384
+35,366
+30% +$10.2M 0.13% 167
2025
Q4 		$35.5M Sell
117,018
-7,608
-6% -$2.37M 0.13% 165
2025
Q3 		$34.9M Buy
124,626
+36,763
+42% +$10M 0.15% 115
2025
Q2 		$21.2M Buy
87,863
+59,397
+209% +$14M 0.13% 179
2025
Q1 		$6.93M Buy
28,466
+6,517
+30% +$1.96M 0.06% 449
2024
Q4 		$7.21M Buy
21,949
+3,805
+21% +$1.29M 0.07% 408
2024
Q3 		$6.07M Sell
18,144
-10,552
-37% -$3.35M 0.06% 433
2024
Q2 		$7.84M Sell
28,696
-4,690
-14% -$1.36M 0.1% 274
2024
Q1 		$11.5M Sell
33,386
-4,028
-11% -$1.32M 0.17% 104
2023
Q4 		$12.1M Buy
37,414
+14,743
+65% +$4.62M 0.22% 57
2023
Q3 		$8.13M Buy
22,671
+17,891
+374% +$6.9M 0.17% 114
2023
Q2 		$1.81M Buy
4,780
+1,957
+69% +$796K 0.04% 576
2023
Q1 		$1.35M Buy
2,823
+768
+37% +$360K 0.03% 647
2022
Q4 		$864K Buy
2,055
+144
+8% +$58.1K 0.02% 734
2022
Q3 		$797K Sell
1,911
-1,465
-43% -$730K 0.02% 726
2022
Q2 		$1.67M Sell
3,376
-3,236
-49% -$1.69M 0.05% 425
2022
Q1 		$3.72M Sell
6,612
-1,035
-14% -$624K 0.12% 217
2021
Q4 		$5.78M Buy
7,647
+6,125
+402% +$4.58M 0.19% 131
2021
Q3 		$1.14M Sell
1,522
-1,269
-45% -$951K 0.05% 457
2021
Q2 		$1.8M Sell
2,791
-3,233
-54% -$1.97M 0.08% 340
2021
Q1 		$3.44M Buy
6,024
+4,376
+266% +$2.59M 0.15% 193
2020
Q4 		$961K Sell
1,648
-620
-27% -$353K 0.03% 549
2020
Q3 		$1.17M Sell
2,268
-12,613
-85% -$6.39M 0.04% 497
2020
Q2 		$6.72M Sell
14,881
-3,189
-18% -$1.41M 0.2% 131
2020
Q1 		$6.33M Sell
18,070
-1,947
-10% -$716K 0.18% 167
2019
Q4 		$7.41M Buy
20,017
+1,498
+8% +$528K 0.14% 210
2019
Q3 		$6.16M Buy
18,519
+11,411
+161% +$3.72M 0.11% 241
2019
Q2 		$2.22M Buy
7,108
+4,731
+199% +$1.42M 0.04% 478
2019
Q1 		$727K Sell
2,377
-5,026
-68% -$1.36M 0.01% 744
2018
Q4 		$1.72M Buy
7,403
+401
+6% +$108K 0.03% 532
2018
Q3 		$2.19M Buy
+7,002
New +$2.17M 0.03% 478
2016
Q2 		– Sell
-67,705
Closed -$9.26M – 953
2016
Q1 		$9.26M Sell
67,705
-23,582
-26% -$3.1M 0.1% 304
2015
Q4 		$12.7M Sell
91,287
-24,484
-21% -$3.39M 0.14% 234
2015
Q3 		$15.5M Sell
115,771
-8,510
-7% -$1.22M 0.15% 209
2015
Q2 		$18.7M Sell
124,281
-174,636
-58% -$25M 0.16% 213
2015
Q1 		$40.4M Buy
298,917
+57,943
+24% +$7.18M 0.31% 117
2014
Q4 		$29.1M Buy
240,974
+236,762
+5,621% +$27.2M 0.24% 156
2014
Q3 		$478K Buy
+4,212
New +$499K ﹤0.01% 772

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gotham Asset Management's BIO Position: Q1 2026 in Review

Gotham Asset Management increased its Bio-Rad Laboratories Class A (BIO) stake by 30% in Q1 2026, buying an estimated $10.2M and bringing the position to 152,384 shares worth $42.5M. The position accounts for 0.13% of the portfolio, ranked #167.

Gotham Asset Management first reported a position in BIO in Q3 2014 and has held it in 38 quarters since. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Gotham Asset Management held 152,384 shares of Bio-Rad Laboratories Class A worth $42.5M as of Q1 2026.
  • Gotham Asset Management bought 35,366 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $10.2M.
  • Bio-Rad Laboratories Class A made up 0.13% of Gotham Asset Management's portfolio in Q1 2026, its #167 holding.
  • Gotham Asset Management first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and has held it in 38 quarters since.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.